前沿论文｜CELL INTELLIGENCE

Clinical Impact of CTLA4 and LAG3 Single-Nucleotide Polymorphisms in Multiple Myeloma Patients Treated With BCMA CAR T-Cell Therapy.

PubMed 2026/09/30 发表Hematol OncolQ1 · IF 4.1（JCR 2025）

Targeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions.

PubMed 2026/09/29 发表Curr Oncol RepQ1 · IF 5.2（JCR 2025）

Next-generation CAR-T cell therapy against cancer: precision engineering, programmable immunity, and emerging clinical frontiers.

PubMed 2026/09/29 发表J Egypt Natl Canc InstQ3 · IF 2.2（JCR 2025）

Next-generation CAR-T therapy for malignant brain tumors: latest updates from the 2026 AACR Annual Meeting.

PubMed 2026/09/28 发表Exp Hematol OncolQ1 · IF 17.5（JCR 2025）

Is there a role for palliative care in CAR T-cell therapy?

PubMed 2026/09/28 发表Curr Opin Support Palliat CareQ3 · IF 2.3（JCR 2025）

Current management of central nervous system involvement in chronic lymphocytic leukemia/small lymphocytic lymphoma.

PubMed 2026/09/28 发表Int J HematolQ3 · IF 1.9（JCR 2025）

Correction: CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions.

PubMed 更正 / 勘误 2026/09/28 发表Cancer Cell IntQ1 · IF 7（JCR 2025）

Correction: BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians.

PubMed 更正 / 勘误 2026/09/28 发表Adv TherQ1 · IF 4.7（JCR 2025）

A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.

PubMed 2026/09/27 发表Adv Sci (Weinh)Q1 · IF 14.1（JCR 2025）

Clinical and Therapeutic Relevance of B7-H3 in Sarcomas: Molecular Insights from a Systematic Review.

PubMed 2026/09/27 发表J Drug TargetQ1 · IF 4.7（JCR 2025）

前沿论文 28077